Bharat Parenterals bulk deals, insider trading and stake changes
NSE: BPLPHARMABSE: 541096Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹1,776.00.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹1,165 Cr1,597th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Owners' profit not stated
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 18 May 2026
- 3.6
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.06%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 5 Aug 2026
- −5.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 18 May 2026
- 0.47
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 3,08940.3% delivered
Promoter and insider buying and selling
Trades made since 23 Oct 2025.Bharat Parenterals promoter holding
- Promoters and promoter group2 purchases, 0 sales₹0.31 CrNo saleNetNet. The value bought on the market less the value sold, over the trades whose filers stated a value.₹0.31 Cr
Bharat Parenterals insider trading
All 2 disclosures on record.Insider trading, all companies
Jun 2026
- Desai Shares and Stock Private Limited₹0.18 Cr1,356 sharesBought · Promoter · 15 Jun 2026 · disclosed 26 Jun · stake 39.65% before, 39.67% after
- Desai Shares and Stock Private Limited₹0.13 Cr900 sharesBought · Promoter · 3 Jun 2026 · disclosed 15 Jun · stake 39.63% before, 39.65% after
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Bharat Parenterals stake sales and purchases
All 7 disclosures on record.
Jun 2026
- AcquiredDesai Shares & Stock Pvt Ltd · promoter0.01% of the company1,356 sharesholds 39.67% after25 Jun 2026 · filed under the 2% rule · Market
- AcquiredDesai Shares & Stocks Pvt Ltd · promoter0.01% of the company900 sharesholds 39.64% after15 Jun 2026 · filed under the 2% rule · Market
Oct 2024
- AcquiredVarenyam Healthcare Pvt Ltd · promoter0.24% of the company16,261 sharesholds 0.24% after29 Oct 2024 · filed under the 2% rule · Preferential allotment
- AcquiredNikita B Desai · promoter1.22% of the company84,267 sharesholds 1.22% after29 Oct 2024 · filed under the 2% rule · Preferential allotment
- AcquiredHimaben B Desai · promoter2.60% of the company1,79,069 sharesholds 13.97% after29 Oct 2024 · filed under the 2% rule · Preferential allotment
- AcquiredBharatkumar R Desai · promoter140 sharesholds 10.76% after29 Oct 2024 · filed under the 2% rule · Preferential allotment
- AcquiredBhahim B Desai · promoter1.27% of the company87,779 sharesholds 1.32% after29 Oct 2024 · filed under the 2% rule · Preferential allotment
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Bharat Parenterals bulk deals
None in the last 12 months, since 23 Oct 2025.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Friday 28 Feb 20252 firms · ₹6.61 Cr bought · ₹6.61 Cr soldNet nil
- SoldNEO APEX SHARE BROKING SERVICES LLPSold 75,271 at ₹878.001.09% of the company₹6.61 Cr
- BoughtSETU SECURITIES PRIVATE LIMITEDBought 75,271 at ₹878.001.09% of the company₹6.61 Cr
A bulk deal is one client trading half a per cent or more of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. 1 deal on record since listing on 21 Mar 2018.